Companies are looking for new ways to deliver high quality and reduced costs amid a dynamic business environment and unrelenting financial pressure. These challenges are compounded for pharmaceutical companies, where software testing consumes additional resources due to Guidelines for Pharmaceuticals (GxP) and Sarbanes Oxley (SOX) compliance obligations.